Janet Napolitano and Renaissance Technologies filed reports regarding buying and selling shares of Vir Biotechnology stock with the SEC.

The entities involved

• VIR Biotechnology →

  biotech company

  Nothing else this week.

• Renaissance Technologies →

  American hedge fund firm

  • Renaissance Technologies holds a significant stake in Lite Strategy, Inc., whose stock trades on the Nasdaq exchange.Sun 19:54
  • A company acquired a new position in Freeport-McMoRan shares, leading to required 13F filings with the SEC on June 6, 2026.Sun 19:14
• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12

Related events

• Royal Bank of Canada disclosed growing its stake in National Energy Services Reunited via an SEC filing.Sep 3
• VirnetX stock is traded on the Nasdaq exchange, and a transaction has been disclosed via an SEC filing.Sep 3
• Regeneron Pharmaceuticals filed required reports with the SEC regarding institutional holdings on September 8, 2026.Sep 9
• Rimini Street disclosed a stock sale in a legal filing with the Securities and Exchange Commission.Thu 00:51
• Insider trading and institutional ownership changes related to Madrigal Pharmaceuticals were disclosed to the SEC.Sep 10